Mark Suckle’s Post

Today marks the beginning of Nuclear Medicine and Molecular Imaging Week 2023. This week I’ll share some interesting images and cases to hopefully break the stigma of “unclear” medicine!! #nuclearmedicine #molecularimaging #radiology

Imaging “make the grade”; like this man… certainly, I am in the way to do it in my field: clinical nuclear medicine & molecular imaging as a businessman amd entrepreneur. | The MedicinaNuclearMX collective are Mexican Nuclear Medicine Physicians promoting, expanding clinical use & doing business by private sector in Mexico. #nuclearmedicine #molecularimaging #theranostics #radionuclidetherapy #PETct

As providers of technologies that support the accurate delivery, detection and diagnosis in nuclear medicine and molecular imaging, we support the Mirion Medical commitment to enhance safety at every stage of care. #WorldPatientSafetyDay

💡Application in the spotlight!    In this study by Sankaranarayanan et al., Department of Nuclear Medicine, University Hospital Aachen, RWTH Aachen University, a theranostic approach was investigated in a TNBC xenograft mouse model by radiolabelling a close derivative of a PARPi Olaparib (termed PARPi-01) with the Auger emitters 123/125I.   The γ-cube (SPECT) and X-cube (CT) were used for longitudinal follow-up and evaluation of the biodistribution of [123I]PARPi-01 four h and 24h post-injection.   🔗 Link to the application can be found in the comments! #PreclinicalImaging #PreclinicalResearch #SPECT

For NucMed peers: How many of the professionals who provide services directly for the patients who perform #nuclearmedicine & #molecularimaging with you are payed directly (totally or partially) by your pocket? | The MedicinaNuclearMX collective are Mexican Nuclear Medicine Physicians promoting, expanding clinical use & doing disruptive business by private sector in Mexico.

Good times are coming for nuclear medicine and molecular imaging! In the world tomorrow, there will be greater incorporation of these wonders of modern medical technology. 🙌🏼⭐️🇲🇽🚀 In Mexico and the world, we will need really NucMed physicians promoters committed with effective clinical implementation (not just clumsy academicals)| The MedicinaNuclearMX collective are Mexican Nuclear Medicine Physicians promoting, expanding clinical use & doing disruptive business by private sector in Mexico. #nuclearmedicine #molecularimaging #PETct #radionuclidetherapy #theranostics Data from MEDraysintell

📊 MEDIRAD survey update! In February 2022, the European-funded MEDIRAD project concluded, aiming to enhance the scientific basis and clinical practice of radiation protection in medicine. The project focused on understanding the health effects of low-dose ionising radiation from diagnostic and therapeutic procedures. As part of MEDIRAD, a large survey was conducted in 2019 to gather information on the use of multimodality imaging in nuclear medicine. Now, a follow-up survey has been developed to detect changes in the use of CT in nuclear medicine between 2019 and 2024. Participate now - it should not take more than 5 to 10 minutes! ▶️ https://lnkd.in/dpvEqtVs

The Enchanting Realm of Nuclear Medicine Molecular Imaging" 🌟🧬🔬 Nuclear Medicine Molecular Imaging is akin to having X-ray vision 👓—but on steroids 💪. It offers a peek 👀 into the body’s functions by using radiopharmaceuticals, essentially drugs tagged with radioactive markers ☢️. Picture tagging your keys with glow-in-the-dark stickers 🔑🌟 to find them in the dark 🌃; similarly, we’re tagging molecules to observe their behavior inside the body 🧬. #molim #drugdevelopment

Check out my colleague Dr Hunor Kertesz on The Nuclear Medicine and Molecular Medicine Podcast talking on Positron Range Correction:

#DidYouKnow in the 2010's, the emergence of radiotherapeutics using isotopes like Lu-177 marked a milestone shift in the nuclear medicine market, changing the importance of isotopes in healthcare? The radiotherapeutic market represented 20% of the total nuclear medicine market in 2019, up from 6% in 2013. Through continued investment and innovation, it is projected that radiotherapeutics will represent around 75% of the market by 2031, massively expanding the possibilities for personalized medical treatments!